Literature DB >> 20676563

Seroprevalence of herpes simplex 1-2 antibodies in Brazil.

Sue Ann Costa Clemens1, Calil Kairalla Farhat.   

Abstract

OBJECTIVE: To estimate the seroprevalence of HSV-1 and HSV-2 antibodies in Brazil and to analyze factors associated.
METHODS: Cross-sectional study including subjects aged 1-40 years from the general population in four different geographical areas in Brazil between 1996 and 1997. All subjects were stratified by age and gender and 1,090 of them were included in the final analysis. Blood samples were tested for HSV-1 and HSV-2 antibodies by type-specific (gG1 and gG2) ELISA. Frequencies and proportions were described and compared among groups using two-sided Fisher's exact test. A logistic regression analysis was performed to assess the influence of the variables age, gender, geographical area, socioeconomic condition, past history of STD, seropositivity for anti-HSV-1 or anti-HSV-2 and interactions of any of these factors on the seroprevalence of HSV-1 and/or HSV-2.
RESULTS: The age-adjusted seroprevalences of HSV-1 and HSV-2 antibodies were 67.2% and 11.3%, respectively, without sex differences and being higher in the North region. Seroprevalences increased with age and, for HSV-2 infection, the higher increase was observed among adolescents and young adults. Subjects who tested positive for HSV-1 were more likely to also test positive for HSV-2 (15.7%) compared to HSV-1 negative subjects (4.7%). In the multivariate analysis past history of STD significantly (OR=3.2) increased the likelihood of HSV-2 infection whereas socioeconomic condition did not affect the results.
CONCLUSIONS: HSV-1 and HSV-2 seroprevalences vary with age and among Brazilian regions. Past history of STD is a major risk factor for HSV-2 infection.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20676563     DOI: 10.1590/s0034-89102010000400017

Source DB:  PubMed          Journal:  Rev Saude Publica        ISSN: 0034-8910            Impact factor:   2.106


  16 in total

Review 1.  Risks associated with viral infections during pregnancy.

Authors:  Karen Racicot; Gil Mor
Journal:  J Clin Invest       Date:  2017-05-01       Impact factor: 14.808

2.  Investigation on the association between thyroid tumorigeneses and herpesviruses.

Authors:  J F M Almeida; A H Campos; M A Marcello; N E Bufalo; C L Rossi; L H P Amaral; A B Marques; L L Cunha; C A Alvarenga; P C Tincani; A J Tincani; L S Ward
Journal:  J Endocrinol Invest       Date:  2017-03-08       Impact factor: 4.256

3.  Prevalence and factors associated with HSV-2 and hepatitis B infections among truck drivers crossing the southern Brazilian border.

Authors:  Adriana A Pinho; Magda Chinaglia; Sheri A Lippman; Arthur Reingold; Ricardo Sobhie Diaz; Maria Cecilia Sucupira; Kimberly Page; Juan Díaz
Journal:  Sex Transm Infect       Date:  2011-10-03       Impact factor: 3.519

4.  Seroprevalence of HSV-1/2 and correlation with aggravation of oral mucositis in patients with squamous cell carcinoma of the head and neck region submitted to antineoplastic treatment.

Authors:  Andreza Veruska Lira Correia; Maria Rosângela Cunha Duarte Coêlho; Georgea Gertrudes de Oliveira Mendes Cahú; Jéfferson Luis de Almeida Silva; Catarina da Mota Vasconcelos Brasil; Jurema Freire Lisboa de Castro
Journal:  Support Care Cancer       Date:  2014-12-30       Impact factor: 3.603

5.  Seropositivity and determinants of immunoglobulin-G (IgG) antibodies against Herpes simplex virus (HSV) types -1 and -2 in pregnant women in Port Harcourt, Nigeria.

Authors:  Iheanyi Omezuruike Okonko; Tochi Ifeoma Cookey
Journal:  Afr Health Sci       Date:  2015-09       Impact factor: 0.927

6.  Genotypic Characterization of Herpes Simplex Virus Type 1 Isolates in Immunocompromised Patients in Rio de Janeiro, Brazil.

Authors:  Amanda Perse da Silva; Amanda de Oliveira Lopes; Yasmine Rangel Vieira; Adilson José de Almeida; Fernando Samuel Sion; Beatriz Grinsztejn; Sandra Wagner; Vanessa Salete de Paula
Journal:  PLoS One       Date:  2015-09-25       Impact factor: 3.240

7.  In vivo anti-herpes simplex virus activity of a sulfated derivative of Agaricus brasiliensis mycelial polysaccharide.

Authors:  F T G S Cardozo; I V Larsen; E V Carballo; G Jose; R A Stern; R C Brummel; C M Camelini; M J Rossi; C M O Simões; C R Brandt
Journal:  Antimicrob Agents Chemother       Date:  2013-03-18       Impact factor: 5.191

8.  Seroprevalence and correlates of herpes simplex virus type 2 infection among young adults in Arkhangelsk, Northwest Russia: a population-based cross-sectional study.

Authors:  Tatiana Balaeva; Andrej M Grjibovski; Oleg Sidorenkov; Olga Samodova; Natalia Firsova; Anatoly Sannikov; Elise Klouman
Journal:  BMC Infect Dis       Date:  2016-10-28       Impact factor: 3.090

9.  Seroepidemiology of herpes simplex virus type 1 and 2 in northern iran.

Authors:  S Rezaei-Chaparpordi; M Assmar; N Amirmozafari; L Modiri; A Massiha; S Shokri-Fashtali; Z Gholizadeh; S Akbari
Journal:  Iran J Public Health       Date:  2012-08-31       Impact factor: 1.429

10.  Prevalence of herpes simplex virus type 2 and risk factors associated with this infection in women in southern Brazil.

Authors:  Thaís Duquia Moraes Caldeira; Carla Vitola Gonçalves; Gisele Rodrigues de Oliveira; Tânia Vieira da Fonseca; Regina Gonçalves; Clair Teixeira do Amaral; Vanusa Pousada da Hora; Ana Maria Barral de Martinez
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2013 Sep-Oct       Impact factor: 1.846

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.